Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study

Table 9

Outcome comparison after PSM: Xiyanping combination versus antiviral.

Variable	Xiyanping combination		Antiviral		P
	n	%	n	%
Length of hospital stay	5.88±3.04		6.93±3.08		0.117
CRP difference	39.35±46.94		2.31±10.39		0.062
Neutrophil proportion difference	22.62±12.38		-0.49±14.44		0.003
Neutrophil count difference	3.00±2.73		-3.46±6.31		0.017
White blood cell count difference	2.10±2.69		-3.94±6.84		0.033
Treatment effect
Cure	10	23.3%	15	34.9%	0.235
Turn for the better	27	62.8%	22	51.2%	0.276
Not cured	1	2.3%	1	2.3%	1
Unknown	0	0.0%	1	2.3%	0.314
Death	4	9.3%	2	4.7%	0.397
Others	1	2.3%	2	4.7%	0.557